Home
News
Create
Screeners
Insights
Kobo Biotech
2.
46
-0.06
(-2.38%)
Market Cap
₹5.86 Cr
PE Ratio
-1.19
Industry
Chemicals
Buy
Sell
Company Performance:
1D
-2.38%
1M
-19.08%
6M
+9.33%
1Y
-14.88%
5Y
-58.52%
View Company Insights
Latest news about Kobo Biotech
Kobo Biotech Limited's Committee of Creditors Approves Multiple Resolutions, Including CIRP Extension and Professional Fees
Oct 31, 2025
Kobo Biotech Limited's Committee of Creditors (CoC) has approved several crucial resolutions in its ongoing Corporate Insolvency Resolution Process (CIRP). Key developments include the approval of CVK Technologies Private Limited's resolution plan, extension of CIRP period until January 29, and further extension for submission of resolution plans until April 15, 2025. The CoC also approved Resolution Professional fees, ratified various professional fees, and authorized the forfeiture of a Rs. 1.05 crore deposit from a previous applicant. JM Financial Asset Reconstruction Company Limited holds a 99.12% voting share in the CoC.
Kobo Biotech's Committee of Creditors Approves 90-Day Extension for Insolvency Resolution Process
Oct 31, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO